How Much Does Testosterone Enanthate Cost in Texas in 2026?

Texas Retail Cash Pricing for Testosterone Enanthate

The average cash-pay cost for testosterone enanthate across Texas retail pharmacies is $70 per month in 2026. That figure reflects a 200 mg/mL vial, the most commonly dispensed concentration for weekly intramuscular injection at doses between 100 and 200 mg. The manufacturer list price remains $120 per month, but few patients actually pay that amount.

Price variation across Texas is significant. Pharmacies in the Dallas-Fort Worth metroplex and Houston tend to price 5% to 15% below rural counterparts because of higher prescription volume and wholesaler competition. A 2023 analysis of testosterone formulation costs found that injectable esters like enanthate remain the most cost-effective delivery method compared to transdermal gels and subcutaneous pellets 1. GoodRx and similar aggregator platforms can push the effective cash price below $50 per month at select Texas chains, though availability fluctuates.

Testosterone enanthate is classified as a Schedule III controlled substance under both federal and Texas state law. Prescriptions require a DEA-registered provider, and refills are limited to five within six months of the original prescription date 2.

Insurance Coverage Across Texas Plans

Most major commercial insurers in Texas, including Blue Cross Blue Shield of Texas, Aetna, Cigna, and UnitedHealthcare, cover testosterone enanthate on their formularies when prescribed for a confirmed diagnosis of male hypogonadism. Typical copays fall between $10 and $45 per month on preferred-tier generic formularies. Prior authorization is common.

The Endocrine Society's 2018 clinical practice guideline defines male hypogonadism as a morning total testosterone level below 300 ng/dL on two separate occasions, combined with consistent symptoms such as fatigue, reduced libido, or loss of muscle mass 3. Insurers in Texas typically require documentation of these two low readings before approving coverage. Some plans also mandate a trial of lifestyle modification or a documented pituitary workup.

Step therapy requirements vary. Several Texas plan designs require the prescriber to demonstrate that injectable testosterone is the preferred route before covering alternative formulations. Because testosterone enanthate injections are the lowest-cost option, they are nearly always designated Tier 1 or Tier 2 on Texas formularies. The American Urological Association's 2018 guideline similarly supports injectable testosterone esters as first-line therapy for symptomatic hypogonadism 4.

Texas Medicaid and Testosterone Enanthate

Texas Medicaid does not cover testosterone enanthate for primary or secondary hypogonadism. Coverage is restricted to specific endocrine conditions with documented medical necessity beyond low testosterone alone. This exclusion affects roughly 5.6 million Texas Medicaid enrollees.

Patients who rely on Medicaid and carry a hypogonadism diagnosis have limited options. Applying for manufacturer patient assistance programs or using pharmacy discount cards can reduce cash-pay costs to $40 to $60 per month. The FDA's approved labeling for testosterone enanthate lists the primary indication as replacement therapy in males with conditions associated with a deficiency or absence of endogenous testosterone 5. Despite this approved indication, state Medicaid programs retain formulary discretion.

The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled studies enrolling 790 men aged 65 and older with serum testosterone below 275 ng/dL, showed that one year of testosterone gel treatment improved sexual function, physical activity, and mood compared to placebo 6. These findings have informed national guideline recommendations but have not yet changed Texas Medicaid's formulary position on testosterone replacement.

Compounded Testosterone Enanthate in Texas

Compounded testosterone enanthate is legal in Texas when dispensed by a licensed 503A compounding pharmacy operating under strict Texas State Board of Pharmacy oversight. The average cost for compounded testosterone enanthate from a 503A pharmacy in Texas is approximately $80 per month, slightly above the retail generic cash price.

Texas regulates 503A compounding pharmacies under Chapter 291 of the Texas Administrative Code, requiring patient-specific prescriptions, compliance with USP <797> sterile compounding standards, and routine inspections. The FDA distinguishes between 503A (patient-specific) and 503B (outsourcing facility) compounding, and both pathways operate in Texas 7.

One reason patients choose compounded testosterone: concentration flexibility. Commercial vials come in fixed 200 mg/mL concentrations. Compounding pharmacies can prepare 250 mg/mL or 300 mg/mL concentrations, reducing injection volume for patients on higher doses. A 2021 review of testosterone compounding practices noted that customized concentrations and carrier oils (such as grapeseed or sesame oil) can improve tolerability for patients who experience injection-site reactions with standard formulations 8.

Telehealth TRT Prescribing in Texas

Texas permits testosterone enanthate prescribing via telehealth. The Texas Medical Board allows the establishment of a valid patient-provider relationship through synchronous audio-video consultation without requiring an initial in-person visit for Schedule III controlled substances when clinical criteria are met.

A telehealth-based TRT consultation in Texas typically costs $99 to $199 for the initial visit and $50 to $99 for follow-ups. Lab work, which must include at least a morning total testosterone level, is ordered separately. Many telehealth TRT platforms partner with national reference laboratories (Quest, Labcorp) that maintain draw sites across Texas metro areas.

The 2020 JAMA Internal Medicine analysis of testosterone prescribing trends found that telehealth-facilitated prescriptions increased by 17.8% between 2017 and 2022, with the largest growth in states like Texas that adopted flexible telehealth licensing 9. Patients considering telehealth TRT should confirm that their provider orders both pre-treatment labs and periodic monitoring of hematocrit, PSA, and lipids, as recommended by the Endocrine Society 3.

Discount Programs and Savings Cards

Several discount pathways exist for Texas patients paying cash for testosterone enanthate. Manufacturer copay cards, pharmacy benefit aggregators, and nonprofit patient assistance programs can each reduce monthly spending.

GoodRx, RxSaver, and SingleCare frequently list testosterone enanthate (1 mL of 200 mg/mL) at $30 to $55 per month at Texas Walmart, H-E-B, CVS, and Walgreens locations. These prices represent 30% to 50% savings off the average $70 cash price. The cards work by routing the transaction through a pharmacy benefit manager that has pre-negotiated discount rates with the dispensing pharmacy.

H-E-B, a Texas-based grocery chain with in-store pharmacies, runs its own prescription discount program that occasionally prices generic testosterone enanthate below national aggregator rates. Costco pharmacies in Texas (which do not require a membership for pharmacy services) also tend to offer competitive pricing on generic injectables.

A 2022 study published in JAMA Network Open examined out-of-pocket costs for testosterone across U.S. pharmacies and found that injectable formulations averaged $47 per month at discount pricing, compared to $306 for branded gels 10. This price differential is one reason the AUA guideline identifies injectables as a cost-effective first-line option 4.

Safety Monitoring and Ongoing Lab Costs

The total cost of testosterone replacement extends beyond the drug itself. Guideline-recommended monitoring adds $200 to $500 per year in lab expenses for Texas patients, depending on insurance status.

The Endocrine Society recommends checking hematocrit at baseline, at 3 to 6 months, and then annually during TRT, because testosterone stimulates erythropoiesis and can raise hematocrit above 54%, increasing thrombotic risk 3. A complete blood count at a Texas reference lab costs $15 to $35 cash-pay. Total testosterone, PSA, and a basic metabolic panel add another $50 to $100 per draw.

A 2019 pharmacovigilance study in JAMA found that testosterone therapy was associated with a dose-dependent increase in polycythemia risk, with the highest incidence in men receiving injectable formulations at doses exceeding 200 mg weekly 11. Dose adjustments or therapeutic phlebotomy may be required, adding to the overall cost of care.

The FDA added a boxed warning to testosterone products in 2015 regarding cardiovascular risk in men using testosterone for age-related decline rather than classical hypogonadism 12. The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, subsequently demonstrated that testosterone replacement in men aged 45 to 80 with hypogonadism and cardiovascular risk factors did not increase the incidence of major adverse cardiovascular events compared to placebo over a mean follow-up of 33 months 13.

Injectable vs. Alternative Formulations: Cost Comparison in Texas

Testosterone enanthate injections are the least expensive TRT option available in Texas. Here is how the major formulations compare on a monthly cash-pay basis at Texas retail pharmacies in 2026:

• Testosterone enanthate (generic injectable): $70 per month
• Testosterone cypionate (generic injectable): $65 to $80 per month
• Testosterone gel 1% (generic): $90 to $180 per month
• AndroGel 1.62% (brand): $500 to $600 per month
• Testosterone pellets (Testopel): $300 to $700 per insertion every 3 to 6 months
• Jatenzo (oral testosterone undecanoate): $700 to $900 per month
• Natesto (nasal testosterone): $500 to $800 per month

A 2020 cost-effectiveness analysis in the Journal of Urology confirmed that injectable testosterone esters provide the highest quality-adjusted life year (QALY) value among available TRT formulations 14. For a patient paying $70 per month ($840 per year) plus $300 in annual labs, the total annual cost of injectable TRT in Texas is approximately $1,140 before any discount card savings.

Testosterone cypionate and enanthate are pharmacologically near-identical, both being long-chain fatty acid esters with half-lives of approximately 8 days. The choice between them often comes down to pharmacy stock and minor price differences. The Endocrine Society does not express a preference between the two esters 3.

How to Minimize Your TRT Costs in Texas

Texas patients have several concrete strategies to reduce testosterone enanthate spending:

Use a pharmacy discount card at every fill. Even insured patients should compare their copay against the GoodRx or SingleCare cash price, because the discount price occasionally beats a high-deductible plan copay.

Request a 10 mL multidose vial. A 10 mL vial of testosterone enanthate 200 mg/mL contains enough medication for 10 to 20 weeks of treatment depending on dose. The per-unit cost of a multidose vial is 30% to 50% lower than 1 mL single-dose vials.

Consider a 503A compounding pharmacy for custom concentrations. If you require a non-standard dose or have injection-site sensitivity, a compounded product at $80 per month may eliminate the need for more expensive topical alternatives.

Bundle labs through a direct-access laboratory. Texas law permits patients to order their own blood tests without a physician order through direct-access testing. Companies like Walk-In Lab and Personalabs offer testosterone and CBC panels for $50 to $90, compared to $150 or more through a hospital outpatient lab.

A population-level analysis of testosterone prescribing published in the Annals of Internal Medicine noted that out-of-pocket costs are a primary driver of TRT discontinuation, with 28.4% of men citing cost as the reason for stopping therapy within the first year 15. Reducing cost barriers improves adherence and clinical outcomes.

The CDC reports that hypogonadism prevalence increases with age, affecting an estimated 20% of men over 60 and 30% of men over 70, making cost-effective access to testosterone replacement a growing public health priority 16.